Modifying Exercise for the COPD Patient

Modifying Exercise for the COPD Patient With Arthritic Limitations to Improve Compliance in a Pulmonary Rehab Program

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02143206

Enrollment

Registered

2014-05-20

Start date

2012-09-30

Completion date

2014-05-31

Last updated

2018-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis, Chronic Obstructive Pulmonary Disease, Pain

Keywords

Chronic Obstructive Pulmonary Disease, Pain, Arthritis, Dyspnea, Exercise, Aerobic

Brief summary

This study will test whether using the Biodex BioStep Semi Recumbent Elliptical for the chronic obstructive pulmonary disease (COPD) patient with arthritic limitations will improve participation in a pulmonary rehab program compared to the Nustep elliptical. The main outcome of participation will be measured by the number of exercise sessions the patient is able to complete during their pulmonary rehabilitation program. In addition, distance walked in six minutes, dyspnea score, rate of perceived exertion (RPE) score, Pain Scale Index score, and finally, the Dartmouth Quality of Life index (DQL) will be assessed in both groups. It is believed that the new machine will provide better overall outcomes compared to the traditional machine.

Detailed description

A Prospective cohort study of 25 COPD patients with osteoarthritis undergoing an exercise plan in a pulmonary rehab program. Patient pain level, clinical outcomes, and ultimately, quality of life outcomes will be assessed in order to assess whether future compliance for COPD arthritic patients will occur in an exercise rehabilitation program.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

* COPD Patient * Osteoarthritic limitations in upper or lower extremities, or spine * Forced Expiratory Volume (FEV)1 less than 70% * Forced Expiratory Volume/Forced Vital Capacity (FEV/FVC) ratio less than 70%

Exclusion criteria

* Patients with rheumatoid arthritis

Design outcomes

Primary

Measure	Time frame
Number of Exercise Sessions Attended	2 years

Secondary

Measure	Time frame
Distance Walked	6 minutes

Other

Measure	Time frame
Dyspnea Score	Two years
Rate of Perceived Exertion	30 minutes
Pain Index Score	30 minutes
Dartmouth Quality of Life Index	1 year

Countries

United States

Outcome results